PMDA drug package insert
サヴィオゾール輸液
PMDA Prescription drug · 株式会社大塚製薬工場 · package insert Mar 24, 2023
Key facts
| Brand names | サヴィオゾール輸液 |
|---|---|
| Nonproprietary names | 乳酸リンゲル液（デキストラン４０加） |
| Companies | 製造販売元／株式会社大塚製薬工場, 販売提携／大塚製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 血漿増量・体外循環灌流液 |
| Therapeutic category codes | 873319 |
| YJ codes | 3319554A4043 |
| Approval numbers | 22100AMX01268 |
| Package insert edition | 第1版 |
| Package insert date | Mar 24, 2023 |
| PMDA document key | 180079_3319554A4043_1 |
| PMDA company code | 180079 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: